Financing - October 4, 2013
Pharmalink raises SEK 96 million
The Swedish company Pharmalink has raised SEK 96 million to undertake pivotal studies with lead programs in cancer therapy and renal disease. Pharmalink, a specialty pharma company focused on orphan and niche products, today announces it has raised SEK96 million (€11m / US$15m) in a Series C financing round. The round was co-led by two […]
Biotech Business - August 6, 2013
Multi-million euro investment for biobased products
48 companies team up with the European Commission to set up a public-private partnership and accelerate the deployment of biobased products in Europe. The European Commission have proposed a €3.8 billion Public Private Partnership (PPP) on Biobased Industries. From 2014 to 2020, the European Commission will invest €1 billion and industry €2.8 billion to boost […]
